Drug-induced psychosis associated with crystalline methamphetamine

Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
Glenys Dore, Melinda Sweeting

Abstract

A case of drug-induced psychosis related to crystalline methamphetamine is described, highlighting the phenomenology and relevant treatment. A 44-year-old woman with borderline personality traits and severe drug dependence developed a protracted drug-induced psychosis related to chronic high-dose crystalline methamphetamine use. Complete resolution of symptoms occurred with antipsychotic medication and abstinence from methamphetamine. Rapid recurrence of symptoms occurred at a time of high stress associated with minimal methamphetamine use and cessation of low-dose quetiapine. Symptoms rapidly resolved with abstinence, quetiapine and reduction of stressors. A drug-induced psychosis resembling paranoid schizophrenia can occur with repeated or high-dose use of methamphetamine. While this generally resolves rapidly with cessation of stimulant use, some cases of protracted drug-induced psychosis in vulnerable individuals have been documented. Behavioural sensitization can also occur, and neuroleptics may prevent the recurrence of further psychosis triggered by ongoing low-dose methamphetamine use.

References

Jan 1, 1992·Schizophrenia Bulletin·M SatoT Hamamura
Nov 1, 2001·The Cochrane Database of Systematic Reviews·M SrisurapanontN Jarusuraisin
May 11, 2002·Current Psychiatry Reports·Hiroshi Ujike
Feb 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Louise ArseneaultRobin M Murray

❮ Previous
Next ❯

Citations

Dec 23, 2014·Case Reports in Psychiatry·Ruohollah SeddighBehnam Shariati
Feb 15, 2016·Drug and Alcohol Dependence·Rebecca McKetinJohn B Saunders
Oct 26, 2010·La Presse médicale·Laurent KarilaMichel Reynaud
Sep 21, 2010·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Leo J SchepD Michael G Beasley
Nov 9, 2016·Iranian Journal of Psychiatry and Behavioral Sciences·Mercede SamieiReza Daneshmand
Jun 23, 2010·British Journal of Clinical Pharmacology·Laurent KarilaSteven L Batki
Apr 12, 2011·The American Journal on Addictions·Kazufumi AkiyamaKazutaka Shimoda
May 23, 2014·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Byung Dae LeeHyo Deog Rim
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Steven J ShoptawWalter Ling
Apr 13, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Zahra Alam MehrjerdiAlireza Noroozi
Nov 29, 2013·The Journal of Nervous and Mental Disease·Tania LecomteWilliam G Honer
Apr 24, 2007·Neurotoxicity Research·Jean Lud CadetJohnalyn Lyles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of the American Academy of Child and Adolescent Psychiatry
R E UlloaM Baugher
Archives of General Psychiatry
David A SolomonMartin B Keller
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
C Todorov, A Bazinet
Expert Opinion on Pharmacotherapy
Praveen Dayalu, Kelvin L Chou
© 2022 Meta ULC. All rights reserved